Healthcare / Health Information ServicesToronto
$0.84
-0.05 (-5.62%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 18%
FCF escenarios
weak_data · normalized FCF $-2.4M · quality 45.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
15/100
F
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$78M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-284.6%
↓Gross Margin
N/A
•Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+56.4%
FCF CAGR
—
FCF margin
-881.7%
FCF / Net income
0.73x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $432495.0 · net income $-5.2M · FCF $-3.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $432495.00 | $432495.00 | $456127.00 | $89267.00 | $113031.00 |
| Net Income | $-5.2M | $-5.2M | $-3.3M | $-14.2M | $-13.4M |
| EBITDA | $-5.2M | $-5.2M | $-3.3M | $-5.2M | $-7.3M |
| EPS | -0.07 | -0.07 | -0.05 | -0.28 | -0.34 |
| Operating Margin | -1207.3% | -1207.3% | -730.5% | -6563.1% | -7017.6% |
| Net Margin | -1207.3% | -1207.3% | -730.5% | -15872.7% | -11897.3% |
| Balance Sheet | |||||
| Current Ratio | 4.34 | 4.34 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-3.8M | $-3.8M | $-2.3M | $-2.4M | $-4.9M |
| Returns | |||||
| ROE | -284.6% | -284.6% | 1678.0% | -1305.3% | -165.8% |
| Valuation | |||||
| P/B | 36.05 | 36.05 | — | 20.14 | 1.32 |
| Growth & Yield | |||||
| Revenue Growth | -5.2% | -5.2% | 411.0% | -21.0% | — |
| EPS Growth | -40.0% | -40.0% | 82.1% | 17.6% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-37.8%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.05 → -0.07
Residual
-37.8%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.